Sotirios Parashos, MD, PhD
Dr. Sotirios A. Parashos is a neurologist with the Park Nicollet Clinic and HealthPartners, Clinical Research Lead at the Struthers Parkinson's Center - a Parkinson's Foundation Center of Excellence - and Clinical Professor of Neurology at the University of Minnesota. He completed his basic medical training at the Aristotle University in Thessaloniki, Greece, a two-year Fogarty Fellowship in Neuropharmacology at the Experimental Therapeutics Branch of the NINDS/NIH in Bethesda, MD, a Neurology residency at the University of Minnesota in Minneapolis, MN, a PhD in Experimental Physiology of the Nervous System at the Aristotle University, and an Advanced Clinical Fellowship in Movement Disorders at the Mayo Clinic in Rochester, MN. He serves on the Community Advisory Board of the Struthers Parkinson's Center, the Work Group for Parkinson's Disease Physician Performance Measure Development of the American Academy of Neurology, and the Parkinson Outcome Project of the Parkinson's Foundation. His research centers on non-dopa-responsive symptoms of Parkinson's disease, such as postural instability, falls, and cognitive dysfunction, the natural history of Parkinson's, and the role of multidisciplinary and interdisciplinary care in the management of Parkinson's disease. He has co-authored many articles published in peer-reviewed journals, as well as the book "Navigating Life with Parkinson's Disease", and he has given numerous lectures on Parkinson's disease to professional and lay audiences.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:Pharma2BTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:IMPAXTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:TakedaTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:AbbvieTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:AptinyxTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:NeuralyTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:PraxisTopic:Clinical trialDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:ShareholderIneligible company:Abbott LaboratoriesTopic:InvestorDate added:01/18/2023Date updated:09/25/2024
-
Attribution:SelfType of financial relationship:Grant/Research SupportIneligible company:Sun PharmaTopic:Clinical trialDate added:01/25/2023Date updated:09/25/2024